SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (701)9/21/1999 8:16:00 AM
From: Mike McFarland  Read Replies (1) of 4474
 
Ooops, regarding ~30M at 7/8ths...I was not
thinking--the current market cap of Ariad
has nothing to do with what it would cost
to buy up...and I'm supposed to be hoping
for an ARGENT partner anyway, not this silly
talk of a buyout.

Old news: The speakers at the Keystone Gene
Therapy symposium in January 2000--under gene
regulation, are...Ariad's Victor Rivera, and
O'Malley--Baylor, and Bujard--Univ of Heidelberg.
See www.Symposia.com.

Dang, Ariad could take a lesson from Avigen...yet
another PR from them today:
biz.yahoo.com
One think about Ariad--they'll never be accused of
hyping, that's for sure.

Okay, no more noise from me this week, too
rummy on graveyards to say anything intelligible
anyway:-) Goodnight!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News